GSK and SCYNEXIS Announce an Exclusive Agreement to Commercialise and Further Develop…
<!-- Name:DistributionId Value:8798603 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
BREXAFEMME
BREXAFEMME® (ibrexafungerp tablets) Added to Major National Formulary, Providing…
JERSEY CITY, N.J., Dec. 20, 2021 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and…
BREXAFEMME® (Ibrexafungerp Tablets) Receives 2021 Popular Science Best of What’s New…
JERSEY CITY, N.J., Dec. 01, 2021 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and…